Profound Medical Corp. (PRN)
TSX
10.14
+0.50 (+5.19%)
Closed
Nov 6, 2026
Day's Range
8.6010.19
52 wk Range
6.5212.40
Financial Statements - PRN - Profound Medical Corp.
Revenue
16.09M▲ 50.7%
Net Income
-42.57M▼ 53.0%Net Margin -264.4%
EBITDA
-38.56M▼ 7.3%
Free Cash Flow
-38.44M▼ 63.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 16.09M | 10.68M | 7.19M | 9.70M | 9.98M | 10.61M |
| Cost of Goods | 4.70M | 3.64M | 2.81M | 5.31M | 5.69M | 5.56M |
| Gross Profit | 11.39M | 7.03M | 4.38M | 4.38M | 4.28M | 5.04M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -41.25M | -33.06M | -28.61M | -43.01M | -44.01M | -27.40M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -2.13M | 3.80M | -807K | 437.35K | 10.17K | -4.15M |
| Pre Tax Income | -42.31M | -27.81M | -28.69M | -41.23M | -44.45M | -31.35M |
| Income Tax | 252K | -2K | -128K | 417.01K | 152.56K | 65.38K |
| Net Income | -42.57M | -27.81M | -28.56M | -41.65M | -44.60M | -31.41M |
| EPS Basic | -1.41 | -1.12 | -1.35 | -1.38 | -1.5 | -1.25 |
| EPS Diluted | -1.41 | -1.12 | -1.35 | -1.38 | -1.5 | -1.25 |
| Basic Shares Outstanding | 30.23M | 18.04M | 14.72M | 20.77M | 20.46M | 17.29M |
| Diluted Shares Outstanding | 30.23M | 18.04M | 14.72M | 20.77M | 20.46M | 17.29M |
| Ebit | -41.25M | -33.06M | -27.92M | -40.98M | -44.35M | -30.56M |
| Ebitda | -38.56M | -35.93M | -25.97M | -39.09M | -41.63M | -24.16M |
| Net Income Continuous Operations | -42.57M | -27.81M | -28.56M | -41.65M | -44.60M | -31.41M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
